These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8478872)

  • 1. Developing consensus on preliminary core efficacy endpoints for rheumatoid arthritis clinical trials. OMERACT Committee.
    Tugwell P; Boers M
    J Rheumatol; 1993 Mar; 20(3):555-6. PubMed ID: 8478872
    [No Abstract]   [Full Text] [Related]  

  • 2. OMERACT and the clinical evaluation of new therapeutic agents: a bird's eye view. OMERACT Committee.
    Strand V
    J Rheumatol; 1993 Mar; 20(3):588-9. PubMed ID: 8478881
    [No Abstract]   [Full Text] [Related]  

  • 3. The validity of pooled outcome measures (indices) in rheumatoid arthritis clinical trials.
    Boers M; Tugwell P
    J Rheumatol; 1993 Mar; 20(3):568-74. PubMed ID: 8478876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced joint counts in rheumatoid arthritis clinical trials. American College of Rheumatology Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials.
    Arthritis Rheum; 1994 Apr; 37(4):463-4. PubMed ID: 8147921
    [No Abstract]   [Full Text] [Related]  

  • 5. [Procedure for the evaluation of anti-inflammatory and analgesic agents for the treatment of chronic rheumatoid arthritis: a standard adopted by the Drug Evaluation Committee of the Japan Rheumatism Association].
    Shichikawa K; Sugawara S; Azuma T; Aritomi H; Igarashi M; Ichikawa Y; Saito T; Torisu T; Nishioka K; Maoda A
    Ryumachi; 1983 Aug; 23(4):254-67. PubMed ID: 6364387
    [No Abstract]   [Full Text] [Related]  

  • 6. International consensus on which measures to use in rheumatoid arthritis clinical trials.
    Boers M
    Neth J Med; 1993 Aug; 43(1-2):55-8. PubMed ID: 7694164
    [No Abstract]   [Full Text] [Related]  

  • 7. [Indication for a modern therapy of rheumatoid arthritis].
    Pappalardo A; Compagno M
    Clin Ter; 1998; 149(2):135-8. PubMed ID: 9780479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mefenamic acid in the therapy of rheumatoid arthritis. Clinical experiments and biohumoral control with the double-blind method. (Preliminary observations)].
    D'Ingianna E
    Reumatismo; 1967; 19(3):180-2. PubMed ID: 4890710
    [No Abstract]   [Full Text] [Related]  

  • 9. Important factors in the success and failure of clinical trials (closing remarks).
    Huskisson EC
    Agents Actions Suppl; 1980; 7():323-4. PubMed ID: 6941683
    [No Abstract]   [Full Text] [Related]  

  • 10. Minimal disease activity for rheumatoid arthritis: a preliminary definition.
    Wells GA; Boers M; Shea B; Brooks PM; Simon LS; Strand CV; Aletaha D; Anderson JJ; Bombardier C; Dougados M; Emery P; Felson DT; Fransen J; Furst DE; Hazes JM; Johnson KR; Kirwan JR; Landewé RB; Lassere MN; Michaud K; Suarez-Almazor M; Silman AJ; Smolen JS; Van der Heijde DM; van Riel PL; Wolfe F; Tugwell PS
    J Rheumatol; 2005 Oct; 32(10):2016-24. PubMed ID: 16206362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigational agents for rheumatoid arthritis.
    Merkel PA; Letourneau EN; Polisson RP
    Rheum Dis Clin North Am; 1995 Aug; 21(3):779-96. PubMed ID: 8619099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of efficacy of proquazone in chronic rheumatoid arthritis].
    Shichikawa K; Azuma T; Ogawa N
    Ryumachi; 1982 Jun; 22(3):275-83. PubMed ID: 6750811
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of the test on efficacy of alclofenac in chronic rheumatoid arthritis].
    Ryumachi; 1980 Sep; 20(4):305-21. PubMed ID: 6108616
    [No Abstract]   [Full Text] [Related]  

  • 14. Biostatistical aspects in testing anti-inflammatory agents.
    Rahlfs VW
    Int Z Klin Pharmakol Ther Toxikol; 1971 Oct; 5(2):187-95. PubMed ID: 5137325
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical evaluation of mepirizole (DA-398) in the treatment of chronic rheumatoid arthritis].
    Shiokawa Y; Kageyama T; Sakuma A
    Ryumachi; 1973 Apr; 13(2):206-20. PubMed ID: 4581124
    [No Abstract]   [Full Text] [Related]  

  • 16. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial.
    Pincus T; Strand V; Koch G; Amara I; Crawford B; Wolfe F; Cohen S; Felson D
    Arthritis Rheum; 2003 Mar; 48(3):625-30. PubMed ID: 12632413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials in rheumatoid arthritis.
    Standel W
    Eur J Rheumatol Inflamm; 1982; 5(4):503-6. PubMed ID: 6759135
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical efficacy of the new anti-inflammatory agent Azapropazone].
    Sausgruber H
    Arzneimittelforschung; 1971 Aug; 21(8):1230-4. PubMed ID: 4938489
    [No Abstract]   [Full Text] [Related]  

  • 19. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.
    Aletaha D; Landewe R; Karonitsch T; Bathon J; Boers M; Bombardier C; Bombardieri S; Choi H; Combe B; Dougados M; Emery P; Gomez-Reino J; Keystone E; Koch G; Kvien TK; Martin-Mola E; Matucci-Cerinic M; Michaud K; O'Dell J; Paulus H; Pincus T; Richards P; Simon L; Siegel J; Smolen JS; Sokka T; Strand V; Tugwell P; van der Heijde D; van Riel P; Vlad S; van Vollenhoven R; Ward M; Weinblatt M; Wells G; White B; Wolfe F; Zhang B; Zink A; Felson D
    Ann Rheum Dis; 2008 Oct; 67(10):1360-4. PubMed ID: 18791055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Method for initial evaluation of the action of antiinflammatory agents in rheumatoid arthritis].
    Bonollo L; Acocella G; Manzini A; Marchetti M; Nicolis FB
    Boll Chim Farm; 1972 Jan; 111(1):35-46. PubMed ID: 4555648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.